Recent Progress in the Medical Therapy of Pituitary Tumors

Management of pituitary tumors is multidisciplinary, with medical therapy playing an increasingly important role. With the exception of prolactin-secreting tumors, surgery is still considered the first-line treatment for the majority of pituitary adenomas. However, medical/pharmacological therapy pl...

Full description

Bibliographic Details
Published in:Endocrinology and Metabolism
Main Authors: Fabienne Langlois, Shirley McCartney, Maria Fleseriu
Format: Article
Language:English
Published: Korean Endocrine Society 2017-05-01
Subjects:
Online Access:https://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-32-162.pdf
_version_ 1857126975021252608
author Fabienne Langlois
Shirley McCartney
Maria Fleseriu
author_facet Fabienne Langlois
Shirley McCartney
Maria Fleseriu
author_sort Fabienne Langlois
collection DOAJ
container_title Endocrinology and Metabolism
description Management of pituitary tumors is multidisciplinary, with medical therapy playing an increasingly important role. With the exception of prolactin-secreting tumors, surgery is still considered the first-line treatment for the majority of pituitary adenomas. However, medical/pharmacological therapy plays an important role in controlling hormone-producing pituitary adenomas, especially for patients with acromegaly and Cushing disease (CD). In the case of non-functioning pituitary adenomas (NFAs), pharmacological therapy plays a minor role, the main objective of which is to reduce tumor growth, but this role requires further studies. For pituitary carcinomas and atypical adenomas, medical therapy, including chemotherapy, acts as an adjuvant to surgery and radiation therapy, which is often required to control these aggressive tumors. In the last decade, knowledge about the pathophysiological mechanisms of various pituitary adenomas has increased, thus novel medical therapies that target specific pathways implicated in tumor synthesis and hormonal over secretion are now available. Advancement in patient selection and determination of prognostic factors has also helped to individualize therapy for patients with pituitary tumors. Improvements in biochemical and “tumor mass” disease control can positively affect patient quality of life, comorbidities and overall survival. In this review, the medical armamentarium for treating CD, acromegaly, prolactinomas, NFA, and carcinomas/aggressive atypical adenomas will be presented. Pharmacological therapies, including doses, mode of administration, efficacy, adverse effects, and use in special circumstances are provided. Medical therapies currently under clinical investigation are also briefly discussed.
format Article
id doaj-art-1cb3b93ee0f8422a8d218052d7b852b8
institution Directory of Open Access Journals
issn 2093-596X
2093-5978
language English
publishDate 2017-05-01
publisher Korean Endocrine Society
record_format Article
spelling doaj-art-1cb3b93ee0f8422a8d218052d7b852b82025-08-19T19:06:55ZengKorean Endocrine SocietyEndocrinology and Metabolism2093-596X2093-59782017-05-0132216217010.3803/EnM.2017.32.2.162Recent Progress in the Medical Therapy of Pituitary TumorsFabienne Langlois0Shirley McCartney1Maria Fleseriu2Department of Medicine, Endocrinology and Metabolism, University of Sherbrooke, Sherbrooke, QC, Canada.Department of Neurological Surgery, Oregon Health & Science University, Portland, OR, USA.Department of Medicine, Oregon Health & Science University, Portland, OR, USA.Management of pituitary tumors is multidisciplinary, with medical therapy playing an increasingly important role. With the exception of prolactin-secreting tumors, surgery is still considered the first-line treatment for the majority of pituitary adenomas. However, medical/pharmacological therapy plays an important role in controlling hormone-producing pituitary adenomas, especially for patients with acromegaly and Cushing disease (CD). In the case of non-functioning pituitary adenomas (NFAs), pharmacological therapy plays a minor role, the main objective of which is to reduce tumor growth, but this role requires further studies. For pituitary carcinomas and atypical adenomas, medical therapy, including chemotherapy, acts as an adjuvant to surgery and radiation therapy, which is often required to control these aggressive tumors. In the last decade, knowledge about the pathophysiological mechanisms of various pituitary adenomas has increased, thus novel medical therapies that target specific pathways implicated in tumor synthesis and hormonal over secretion are now available. Advancement in patient selection and determination of prognostic factors has also helped to individualize therapy for patients with pituitary tumors. Improvements in biochemical and “tumor mass” disease control can positively affect patient quality of life, comorbidities and overall survival. In this review, the medical armamentarium for treating CD, acromegaly, prolactinomas, NFA, and carcinomas/aggressive atypical adenomas will be presented. Pharmacological therapies, including doses, mode of administration, efficacy, adverse effects, and use in special circumstances are provided. Medical therapies currently under clinical investigation are also briefly discussed.https://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-32-162.pdfPituitary tumorsPituitary ACTH hypersecretionCushing diseaseAcromegalyProlactinomaNon-functioning pituitary adenomasAtypical pituitary adenomas
spellingShingle Fabienne Langlois
Shirley McCartney
Maria Fleseriu
Recent Progress in the Medical Therapy of Pituitary Tumors
Pituitary tumors
Pituitary ACTH hypersecretion
Cushing disease
Acromegaly
Prolactinoma
Non-functioning pituitary adenomas
Atypical pituitary adenomas
title Recent Progress in the Medical Therapy of Pituitary Tumors
title_full Recent Progress in the Medical Therapy of Pituitary Tumors
title_fullStr Recent Progress in the Medical Therapy of Pituitary Tumors
title_full_unstemmed Recent Progress in the Medical Therapy of Pituitary Tumors
title_short Recent Progress in the Medical Therapy of Pituitary Tumors
title_sort recent progress in the medical therapy of pituitary tumors
topic Pituitary tumors
Pituitary ACTH hypersecretion
Cushing disease
Acromegaly
Prolactinoma
Non-functioning pituitary adenomas
Atypical pituitary adenomas
url https://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-32-162.pdf
work_keys_str_mv AT fabiennelanglois recentprogressinthemedicaltherapyofpituitarytumors
AT shirleymccartney recentprogressinthemedicaltherapyofpituitarytumors
AT mariafleseriu recentprogressinthemedicaltherapyofpituitarytumors